In conclusion, STn is a biomarker of worst prognosis in EC and GLUT1-STn glycoforms may be used to increase its specificity on the stratification and targeting of aggressive ESCC forms. The gene discussed is SLC2A1; the disease is esophageal squamous cell carcinoma.